1 

2 

3 

4 

5 

6 

7 

8 

9 

10 

11 

12 

13 

14 

15 

16 

17 

18 

19 

20 

21 

22 

23 

24 

25 

26 

27 

28 

Ramon Rossi Lopez - rlopez@lopezmchugh.com 

(California Bar Number 86361; admitted pro hac vice) 

Lopez McHugh LLP 

100 Bayview Circle, Suite 5600 

Newport Beach, California 92660 

949-812-5771 

Mark Stephen O’Connor (011029) – mark.oconnor@gknet.com 

Gallagher & Kennedy, P.A. 

2575 East Camelback Road 

Phoenix, Arizona 85016-9225 

602-530-8000 

Counsel for Plaintiffs 

UNITED STATES DISTRICT COURT 

DISTRICT OF ARIZONA 

In Re Bard IVC Filters Products 

Liability Litigation 

No. MD-15-02641-PHX-DGC

SHERR-UNA BOOKER, an individual, 

Plaintiff, 

v. 

C.R. BARD, INC., a New Jersey 

corporation and BARD PERIPHERAL 

VASCULAR, an Arizona corporation, 

Defendants. 

PLAINTIFF’S NOTICE OF FILING 

PUBLIC EXHIBITS TO PLAINTIFFS’ 

OMNIBUS SEPARATE STATEMENT OF 

FACTS IN SUPPORT OF THEIR 

RESPONSE TO DEFENDANTS’ 

MOTION FOR SUMMARY JUDGMENT 

Plaintiff hereby files, attached to this Notice, the public/non-confidential exhibits in 

support of Plaintiffs’ Omnibus Separate Statement of Facts in Support of Their Response 

to Defendants’ Motion For Summary Judgment In The Bellwether Cases. 

DATED this 23rd day of October, 2017. 

GALLAGHER & KENNEDY, P.A. 

By:/s/ Mark S. O’Connor 

Mark S. O’Connor 

2575 East Camelback Road 

Phoenix, Arizona 85016-9225 

LOPEZ McHUGH LLP 

Ramon Rossi Lopez (CA Bar No. 86361) 

Case 2:15-md-02641-DGC Document 8375 Filed 10/23/17 Page 1 of 6
2 

1 

2 

3 

4 

5 

6 

7 

8 

9 

10 

11 

12 

13 

14 

15 

16 

17 

18 

19 

20 

21 

22 

23 

24 

25 

26 

27 

28 

(admitted pro hac vice) 

100 Bayview Circle, Suite 5600 

Newport Beach, California 92660 

Counsel for Plaintiffs 

CERTIFICATE OF SERVICE 

I hereby certify that on this 23rd day of October 2017, I electronically transmitted 

the attached document to the Clerk’s Office using the CM/ECF System for filing and 

transmittal of a Notice of Electronic Filing. 

/s/ Gay Mennuti 

Case 2:15-md-02641-DGC Document 8375 Filed 10/23/17 Page 2 of 6
3 

1 

2 

3 

4 

5 

6 

7 

8 

9 

10 

11 

12 

13 

14 

15 

16 

17 

18 

19 

20 

21 

22 

23 

24 

25 

26 

27 

28 

INDEX OF EXHIBITS 

Para No. 

Ex. No. Description 

1 US FDA Clinical Data Summary of the Simon Nitinol Filter, attached as Exhibit 1, 

BPVE-01-00280772 

2 Deposition of John McDermott, dated Feb. 5, 2014 at 

83:9-92:18; 142:18-144:1; 152:16-154:4; 166:9-168:18; 190:11-195:13; 196:12-197:16; 

228:17-229:8; 288:13-289:7; 290:15-290:25; 306:14 – 308:11; 349:17-21 

3 Product Performance Specification Recovery Filter and Femoral Delivery System, dated 

Nov. 2003, BPVE-01-00010390 

4 Email from D. Ciavarella to Barry & Ganser re G2 Caudal Migrations, dated Dec. 27, 

2005, BPVE-01-00028224 

6 Deposition of Donna B. Tillman, dated June 12, 2014 at 101:20-23, 115:23-116:3, 

119:23-120:7; 193:6-194:20 

11 Deposition of Murray R. Asch, dated May 2, 2016 at12:14-24; 23:7-24:19; 26:8-15; 

195:14-24; 40:19-41:11 

12 Murray R. Asch, MD, FRCPC, Initial Experience in Humans with a New Retrievable 

IVC Filter, Radiology 2002; 225:835-844 (“Asch Study Article”) 

20 Deposition of Robert Carr, dated Dec. 19, 2014 at 120:20–122:1 

22 Deposition of Andrzej Chanduszko, dated Oct. 10, 2013 at 51:23–52:7 

23 Recovery Filter System for use in the Vena Cava, Information for Use, BPVE-01-

00435559 

27 Special Design Review for Recovery (Project #s 7081 and 8008) – Meeting Minutes, 

dated Dec. 9, 2003, BPVE-01-00407525 

28 Email exchange between Janet Hudnall to David Rausch dated Feb. 26-27, 2004, BPVE01-00373887 

30 Email from Alex Tessmer to Robert Carr dated Feb. 25, 2004, BPVE-01-00410985 

31 Characterization of Recovery Filter Migration Resistance in Comparison to Competitive 

Product Phase 1, BPVE-01-00276094 

32 Email from Alex Tessmer to Charlie Benware and others Mar. 24, 2004, BPVE-01-

00330122 

33 Engineering Test Report No. ETR-04-03-02, BPV-17-01-00001198–208 

35 Health Hazard Evaluation, dated Dec. 17, 2004, BPVE-01-01019821 

Case 2:15-md-02641-DGC Document 8375 Filed 10/23/17 Page 3 of 6
4 

1 

2 

3 

4 

5 

6 

7 

8 

9 

10 

11 

12 

13 

14 

15 

16 

17 

18 

19 

20 

21 

22 

23 

24 

25 

26 

27 

28 

37 Deposition of Chad Modra, dated Mar. 28, 2013 at 181:1-19; 183:9-12 

38 Crisis Communication Plan, BPV-17-01-00165419 

39 Email from John Lehman, dated April 15, 2004, BPV-17-01-00165419 

40 Email from Jason Greer to Janet Hudnall, dated Mar. 16, 2006, BPVE-01-00946624 

41 Remedial Action Plan dated April 21, 2004, BPV-17-01-00153578 

42 April 13, 2004, May 8, 2004; May 30, 2004; July 24, 2004; August 16, 2004; November 

15, 2004; November 28, 2004) Recovery Filter Detached Limbs—Patient Comparison 

Matrix dated November 1, 2005, BPV-17-01-00035618 

43 HHE, July 9, 2004, BPV--17-01-00002145 

46 Updated Health Hazard Evaluation, June 30, 2004, BPVEFILTER-01000014836 

47 Bard Recovery FAQ dated July 15, 2004, BPVE-01-00268921-923 

49 Internal Q&A dated Aug. 30, 2004, BPVE-01-00033810 

50 2004 Recovery Marketing Brochure, BPV-17-01-00007760-763 

51 Deposition of Jack Sullivan (Vol. I), dated Sept. 16, 2016 at 54:10-55:6, 56:2-57:2, 

59:15-61:4; 80:16-81:12 

54 Email from Chris Ganser to T. Ring dated April 19, 2005, BPVE-01-00434275 

55 Email from Jason Greer to Nicole Alpie and others dated July 16, 2005, BPV-DEP00005665-666 

56 Executive Summary dated August 3, 2005, BPV-17-01-00170083-084 

57 Janet Hudnall, Avijit Mukherjee, and Robert Carr email chain, August 25-26, 2004, 

BPVE-01-00008821 

59 Email from Janet Hudnall to John McDermott, Feb. 11, 2005, BPVE-01-00167251 

66 Marketing Brochure for Recovery G2 Filter System, BPV-17-01-00137588 

68 Deposition of Christine Brauer, dated May 23, 2014 216:1-217:20; 224:6-225:15 

73 Email chain between Chris Ganser, Gin Schultz, Cindi Walcott, and others, November 7-

14, 2005, BPVE-01-01510714 

Case 2:15-md-02641-DGC Document 8375 Filed 10/23/17 Page 4 of 6
5 

1 

2 

3 

4 

5 

6 

7 

8 

9 

10 

11 

12 

13 

14 

15 

16 

17 

18 

19 

20 

21 

22 

23 

24 

25 

26 

27 

28 

74 Bard internal spreadsheet of Filter Sales and MAUDE data through November 7, 

2005/Q3 2005, BPVE-01-01510717 

76 Email chain between David Ciaverella, Cindi Walcott, and others, December 20-27, 

2015, BPVE-01-00028224 

82 Memo from Brian Barry to John Weiland re Competitive Filter Data, May 2, 2005, BPV01-00098737 

83 Bard IVC filter model sales and complications comparison spreadsheet, BPVEFILTER01-00050487 

85 Binkert, et al., Technical Success and Safety of Retrieval of the G2 Filter in a 

Prospective, Multicenter Study, J. Vasc. Interv. Radiol. 2009 

88 Bard Peripheral Vascular Filter Franchise Review, May 6, 2008, BPVE-01-00622862-

900 

91 Deposition of Patrick McDonald, dated July 29, 2016 at 103:23-104:1 

92 Email chain between Brian Hudson, Kevin Bovee, and Chad Modra, June 28, 2011, 

BPVEFILTER-01-00037661-62 

93 F.C. Lynch & S. Kekulawela, Removal of the G2 Filter: Differences between 

Implantation Times Greater than and Less than 180 Days, 20 J. Vasc. Interv. Radiol. 

1200 (2009) 

94 W. Nicholson et al., Prevalence of Fracture and Fragment Embolization of Bard 

Retrievable Vena Cava Filters and Clinical Implications Including Cardiac Perforation 

and Tamponade, 170 Arch. Intern. Med. 1827 (2010) 

97 Deposition of Christopher Smith, dated Aug. 3, 2017 at 126:6-18, 130:6-20; 141:18-24, 

144:16-20; 155:6-156:4; 156:5-156:25, 158:1-159:5; 184:9-21 

103 Deposition of Abithal Raji-Kubba, dated July 18, 2016 at 167:11-168:8 

110 Deposition of Clement Grassi, M.D, dated July 30, 2014 at126:6-18, 130:6-20; 69:23-

70:10; 232:14-19; 238:2-239:2; 239:3-17; 325:15-326:6 

111 G3 Vena Cava Filter Design Input Summary Report, BPVE-01-0061776 

113 Deposition of David Ciavarella, dated Nov. 12, 2013 at 220:16-221:15 

116 Deposition of Tim Fischer, March 29, 2017 at 7:16-24; 281:13-283:1; 282:4-283:3 

117 Deposition of Mark Moritz, M.D., dated July 18, 2017 at 85:12-86:3 

Case 2:15-md-02641-DGC Document 8375 Filed 10/23/17 Page 5 of 6
6 

1 

2 

3 

4 

5 

6 

7 

8 

9 

10 

11 

12 

13 

14 

15 

16 

17 

18 

19 

20 

21 

22 

23 

24 

25 

26 

27 

28 

J-D 

Bard Peripheral Vascular’s Supplemental Responses to Plaintiffs Doris and 

Alfred Jones’s First Set of Requests for Admissions to Bard Peripheral Vascular, 

Inc. 

J-E Eclipse Vena Cava Filter, Femoral Vein Approach, Instructions for Use 

J-G G2X Vena Cava Filter, Femoral Vein Approach, Instructions for Use 

J-H G2 Filter System, Femoral Vein Approach, Instructions for Use 

J-N BPVEFILTER-01-00002447 

J-O Deposition of Thomas Kinney, M.D., dated June 17, 2017 

J-P Deposition of Anne Roberts, M.D., dated July 7, 2017 

Case 2:15-md-02641-DGC Document 8375 Filed 10/23/17 Page 6 of 6